Although subjects received chemotherapy in addition to trastuzumab and pertuzumab (and thus it is possible that pCR could have been achieved without HER2-directed therapy), our data from human breast cancer biopsies are consistent with data from cultured cell lines. The gene discussed is ERBB2; the disease is breast carcinoma.